ETFs Holding AAVL »    AAVL Historical Stock Prices »
AAVL News Video: Fri, Aug 14, 2015, 10:46 AM — Friday Sector Laggards: Biotechnology, Apparel Stores

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Avalanche Biotechnologies is a clinical-stage biotechnology company focused on discovering and developing gene therapies to treat patients with sight-threatening ophthalmic diseases. Co.'s main product candidate is AVA-101 for the treatment of wet age-related macular degeneration (AMD). AVA-101 enables retinal cells to continuously produce therapeutic levels of a naturally occurring anti-vascular endothelial growth factor protein with a single administration. In addition, Co.'s Ocular BioFactory platform has developed AVA-201, a product candidate for the prevention of wet AMD; and AVA-311, which is being evaluated in preclinical studies for the treatment of juvenile X-linked retinoschisis. Self directed investors in Avalanche Biotechnologies, Inc. will be interested in keeping up with all Avalanche Biotechnologies, Inc. news they can find, both AAVL news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on AAVL. At RediNews, we simplify this task by presenting both AAVL news releases originating from Avalanche Biotechnologies, Inc. itself, and AAVL news from a variety of media outlets. Visitors can browse this news online and through our AAVL RSS news feed.


AAVL News — Articles, Videos, & Press Releases

AAVL is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

GEN News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

AAVL News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.